文献速递肿瘤 PET/CT心脏核医学

前列腺癌82Rb PET/CT肿瘤血流量定量的重测重复性研究

Repeatability of tumor blood flow quantification with 82Rubidium PET/CT in prostate cancer - a test-retest study.
PubMed 文献 · EJNMMI Res · 2019-07-04

本研究纳入10例低至高危前列腺癌患者,在基线及1周内不同日重复进行盆腔与心脏静态和动态82Rb PET/CT,共分析11个原发灶。动态82Rb PET/CT动力学建模测量肿瘤血流量的重复性为32%,组内相关系数0.98;静态晚期摄取重复性较差,仅能识别超过51%的个体内血流量变化。

要点

  • 动态82Rb PET/CT动力学建模测肿瘤血流量重复性32%,ICC 0.98。
  • 静态82Rb PET/CT的SUVmax、SUVmean、SUVpeak重复性分别为51%、53%、58%。
  • 静态法仅能识别个体内超过51%的血流量变化,劣于动态法。

核心结论

  • 动态82Rb PET/CT结合动力学建模测量前列腺癌肿瘤血流量具有高重复性,可识别32%的血流量变化。
  • 静态晚期摄取82Rb PET/CT重复性较差,仅能识别超过51%的个体内血流量变化。

研究设计与样本

  • 招募10例计划接受临床PSMA PET/CT或MRI的低至高危前列腺癌患者。
  • 在基线及1周内不同日重复进行盆腔与心脏静态和动态82Rb PET/CT。
  • 共分析11个原发灶。

主要发现

  • K1的重复性为32%,组内相关系数为0.98。
  • SUVmax的重复性为51%,组内相关系数为0.89。
  • SUVmean的重复性为53%,组内相关系数为0.88。
  • SUVpeak的重复性为58%,组内相关系数为0.88。

关键数值与推荐

  • 动态82Rb PET/CT动力学建模K1可识别32%的肿瘤血流量变化。
  • 静态晚期摄取82Rb PET/CT仅能识别超过51%的个体内血流量变化。

临床怎么用

  • 动态82Rb PET/CT动力学建模可用于前列腺癌肿瘤血流量监测,能识别32%的变化。
  • 静态82Rb PET/CT不适用于检测小于51%的个体内血流量变化。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Non-invasive tumor blood flow (TBF) quantification is a candidate approach for risk stratification and monitoring of prostate cancer patients. Validation data have recently been published on prostate TBF measurement with the widely used positron emission tomography (PET) flow tracer 82Rubidium (82Rb). However, no test-retest data is available for TBF measurement with 82Rb PET in prostate cancer. Such information is important to determine the potential clinical usefulness of the technique. The aim of the present study was to determine the test-retest repeatability of TBF measurement with both dynamic and static 82Rb PET. METHODS: We recruited 10 low-to-high-risk prostate cancer patients scheduled for clinical prostate-specific membrane antigen (PSMA) PET/computed tomography (CT) or magnetic resonance imaging. Pelvic and cardiac static and dynamic 82Rb PET/CT were performed at baseline and repeated on a different day within 1 week. In total, 11 primary lesions were analyzed. RESULTS: For K1, standardized uptake values (SUV)max, SUVmean, and SUVpeak, prostate cancer 82Rb PET TBF has a repeatability of 32%, 51%, 53%, and 58% and an intraclass correlation of 0.98, 0.89, 0.88, and 0.88, respectively. CONCLUSION: Dynamic 82Rb PET/CT with kinetic modeling measures TBF in prostate cancer with high repeatability, which allows identification of blood flow changes of 32%. Static late-uptake 82Rb PET/CT is inferior, and only intra-individual blood flow changes above 51% can hence be recognized.

来源:EJNMMI Res,查看原文。版权归原作者所有。

引用

  1. Jochumsen MR, Bouchelouche K, Nielsen KB, et al. Repeatability of tumor blood flow quantification with 82Rubidium PET/CT in prostate cancer - a test-retest study. EJNMMI Res. 2019. PMID: 31273483. doi:10.1186/s13550-019-0529-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。